MRI of the breast has the highest sensitivity for breast cancer detection among current
clinical imaging modalities and is indispensable for breast imaging practice. While the basis …

The use of neoadjuvant systemic therapy in the treatment of breast cancer patients is
increasing beyond the scope of locally advanced disease. Imaging provides important …

Purpose This study used machine learning classification of texture features from MRI of
breast tumor and peri-tumor at multiple treatment time points in conjunction with molecular …

OBJECTIVE. The objective of our study was to determine the accuracy of preoperative
measurements for detecting pathologic complete response (CR) and assessing residual …

Neoadjuvant chemotherapy (NAC) involves administration of chemotherapeutic agents to
patients with newly diagnosed breast cancer prior to definitive surgical treatment …

Background This study evaluated breast imaging procedures for predicting pathologic
complete response (pCR= ypT0) after neoadjuvant chemotherapy (NACT) for breast cancer …

Breast cancer is a heterogeneous disease, which comprises several molecular and genetic
subtypes, each with characteristic clinicobiologic behavior and imaging patterns. Traditional …

Background We performed a systematic review and meta-analysis to evaluate the
prognostic significance of 18 F-FDG PET and PET/CT for evaluation of responses to …

Purpose To investigate the accuracy of dynamic contrast material–enhanced (DCE) breast
MRI for determining residual tumor size after neoadjuvant chemotherapy (NAC). Materials …

Patients with locally advanced invasive breast cancers are often treated with neoadjuvant
chemotherapy prior to definitive surgical intervention. The primary aims of this approach are …